Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2015 Volume 10 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2015 Volume 10 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Estrogen therapy to treat retinopathy in newborn mice

  • Authors:
    • Wenjing Shi
    • Li Zhu
    • Yuhuan Wang
    • Baoyang Hu
    • Honglei Xiao
    • Guoming Zhou
    • Chao Chen
  • View Affiliations / Copyright

    Affiliations: Department of Neonatology, Children's Hospital of Fudan University, Shanghai 201102, P.R. China, Department of Human Anatomy, Histology and Embryology, Fudan University, Shanghai 200032, P.R. China
  • Pages: 611-617
    |
    Published online on: June 5, 2015
       https://doi.org/10.3892/etm.2015.2554
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to treat retinopathy of prematurity (ROP) with estrogen (E2) so as to elucidate the role of E2 in the pathogenesis of ROP. A total of 120 postnatal 7‑day‑old (P7) C57BL/6J mice were selected and raised in a high‑oxygen environment (75% oxygen) for 5 days, followed by 5 days in normal room air. Different doses of E2 or normal saline (NS) were injected intraperitoneally during different time‑periods, and the mice were divided into 14 groups according dose of E2 injection (0.5‑1.5 µg/0.05 ml) and dosing time. Blood vessel changes and hyperplasia were evaluated in flat‑mounted retina and retinal slices. All mice that were exposed to room air, whether they were administered E2 or NS, showed good vascular development in the flat‑mounted retina at P17. No increase in the number of endothelial cell nuclei in the new blood vessels was observed. In ascending order of E2 dose the numbers of cell nuclei were as follows: 0.18±0.129, 0.28±0.086 and 0.55±0.110. The number in the NS group was 2.12±0.373. When the results of the room‑air groups were compared with those of the hyperoxia groups, a highly significant difference was found in each comparison (P<0.0001). All mice showed varying degrees of neovascularization and vascular obstruction in the flat‑mounted retina at P17, and it was difficult to compare the blood vessels morphologically among these groups. The number of endothelial cell nuclei decreased following E2 injection, and the difference from the NS group exposed to hyperoxia was highly significant (P<0.0001). For all dose levels, the number of cell nuclei was the lowest when the drug was administered during P7‑16, and the difference from the other two time‑periods was statistically significant (P<0.05). When E2 was administered during P7‑16, the number of cell nuclei was 15.5±1.993 in the 0.5‑µg group, 14.23±2.49 in the 1.0‑µg group and 18.05±1.62 in the 1.5‑µg group. No significant difference was found among these three groups (P>0.05). In conclusion, E2 treatment during the development of retinopathy can improve symptoms in neonatal mice, suggesting that E2 plays an important role at the two initial stages in the pathogenesis of ROP. This may indicate new pharmacological measures to prevent and treat ROP.
View Figures

Figure 1

Figure 2

View References

1 

Chen J and Smith LE: Retinopathy of prematurity. Angiogenesis. 10:133–140. 2007. View Article : Google Scholar : PubMed/NCBI

2 

Li Z and Ni WJ: Advances of biological drugs for retinal neovascularization. Guo Ki Yan Ke Za Zhi. 7:1119–1123. 2007.(In Chinese).

3 

No authors listed. An international classification of retinopathy of prematurity. Pediatrics. 74:127–133. 1984.PubMed/NCBI

4 

No authors listed. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. The International Committee for the Classification of the Late Stages of Retinopathy of Prematurity. Arch Ophthalmol. 105:906–912. 1987. View Article : Google Scholar : PubMed/NCBI

5 

Cryotherapy for Retinopathy of Prematurity Cooperative Group, . Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol. 106:471–479. 1988. View Article : Google Scholar : PubMed/NCBI

6 

Cryotherapy for Retinopathy of Prematurity Cooperative Group, . Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Arch Ophthalmol. 108:195–204. 1990. View Article : Google Scholar : PubMed/NCBI

7 

Cryotherapy for Retinopathy of Prematurity Cooperative Group, . Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome - structure and function. Arch Ophthalmol. 108:1408–1416. 1990. View Article : Google Scholar : PubMed/NCBI

8 

Cryotherapy for Retinopathy of Prematurity Cooperative Group, . Multicenter trial of cryotherapy for retinopathy of prematurity. 3 1/2-year outcome - structure and function. Arch Ophthalmol. 111:339–344. 1993. View Article : Google Scholar : PubMed/NCBI

9 

Cryotherapy for Retinopathy of Prematurity Cooperative Group, . Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization. Arch Ophthalmol. 114:417–424. 1996. View Article : Google Scholar : PubMed/NCBI

10 

Greven CM and Tasman W: Rhegmatogenous retinal detachment following cryotherapy in retinopathy of prematurity. Arch Ophthalmol. 107:1017–1018. 1989. View Article : Google Scholar : PubMed/NCBI

11 

Ben-Sira I, Nissenkorn I, Weinberger D, Shohat M, Kremer I, Krikler R and Reisner SH: Long-term results of cryotherapy for active stages of retinopathy of prematurity. Ophthalmology. 93:1423–1428. 1986. View Article : Google Scholar : PubMed/NCBI

12 

Quinn GE, Miller DL, Evans JA, Tasman WE, McNamara JA and Schaffer DB: Measurement of Goldmann visual fields in older children who received cryotherapy as infants for threshold retinopathy of prematurity. Arch Ophthalmol. 114:425–428. 1996. View Article : Google Scholar : PubMed/NCBI

13 

Biglan AW, et al: Progress in ROP research. Chin J Med. 1:7–13. 1990.

14 

Ma DH, Chen JK, Zhang F, Lin KY, Yao JY and Yu JS: Regulation of corneal angiogenesis in limbal stem cell deficiency. Prog Retin Eye Res. 25:563–590. 2006. View Article : Google Scholar : PubMed/NCBI

15 

Mintz-Hittner HA, Kennedy KA and Chuang AZBEAT-ROP Cooperative Group: Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 364:603–615. 2011. View Article : Google Scholar : PubMed/NCBI

16 

Miki K, Miki A, Matsuoka M, Muramatsu D, Hackett SF and Campochiaro PA: Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor. Ophthalmology. 116:1748–1754. 2009. View Article : Google Scholar : PubMed/NCBI

17 

Yatoh S, Kawakami Y, Imai M, Kozawa T, Segawa T, Suzuki H, Yamashita K and Okuda Y: Effect of a topically applied neutralizing antibody against vascular endothelial growth factor on corneal allograft rejection of rat. Transplantation. 66:1519–1524. 1998. View Article : Google Scholar : PubMed/NCBI

18 

Moshfeghi DM and Berrocal AM: Retinopathy of prematurity in the time of bevacizumab: Incorporating the BEAT-ROP results into clinical practice. Ophthalmology. 118:1227–1228. 2011.PubMed/NCBI

19 

O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR and Folkman J: Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:277–285. 1997. View Article : Google Scholar : PubMed/NCBI

20 

Suzuma K, Takagi H, Otani A, Oh H and Honda Y: Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. Am J Pathol. 154:343–354. 1999. View Article : Google Scholar : PubMed/NCBI

21 

Coughlin SR: Thrombin signaling and protease-activated receptors. Nature. 407:258–264. 2000. View Article : Google Scholar : PubMed/NCBI

22 

Shafiee A, Penn JS, Krutzsch HC, Inman JK, Roberts DD and Blake DA: Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1. Invest Ophthalmol Vis Sci. 41:2378–2388. 2000.PubMed/NCBI

23 

Lonchampt M, Pennel L and Duhault J: Hyperoxia/normoxia-driven retinal angiogenesis in mice: A role for angiotensin II. Invest Ophthalmol Vis Sci. 42:429–432. 2001.PubMed/NCBI

24 

Falavarjani KG and Nguyen QD: Adverse events and complications associated with intravitreal injection of anti-VEGF agents: A review of literature. Eye(Lond). 27:787–794. 2013.PubMed/NCBI

25 

Hoerster R, Muether P, Dahlke C, Mehler K, Oberthür A, Kirchof B and Fauser S: Serum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurity. Acta Ophthalmol. 91:e74–e75. 2013. View Article : Google Scholar : PubMed/NCBI

26 

Simoncini T, Maffei S, Basta G, Barsacchi G, Genazzani AR, Liao JK and De Caterina R: Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ Res. 87:19–25. 2000. View Article : Google Scholar : PubMed/NCBI

27 

Ma X, Bi H, Qu Y, Xie X and Li J: The contrasting effect of estrogen on mRNA expression of VEGF in bovine retinal vascular endothelial cells under different oxygen conditions. Graefes Arch Clin Exp Ophthalmol. 249:871–877. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Thompson LP, Pinkas G and Weiner CP: Chronic 17beta-estradiol replacement increases nitric oxide-mediated vasodilation of guinea pig coronary microcirculation. Circulation. 102:445–451. 2000. View Article : Google Scholar : PubMed/NCBI

29 

Suzuma I, Mandai M, Takagi H, Suzuma K, Otani A, Oh H, Kobayashi K and Honda Y: 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci. 40:2122–2129. 1999.PubMed/NCBI

30 

Miyamoto N, Mandai M, Takagi H, Suzuma I, Suzuma K, Koyama S, Otani A, Oh H and Honda Y: Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP. Invest Ophthalmol Vis Sci. 43:2007–2014. 2002.PubMed/NCBI

31 

Takeyama J, Suzuke T, Inoue S, Kaneko C, Nagura H, Harada N and Sasano H: Expression and cellular localization of estrogen receptors and in the human fetus. J Clin Endocrinol Metab. 86:2258–2262. 2001. View Article : Google Scholar : PubMed/NCBI

32 

Gruber CJ, Tschugguel W, Schneeberger C and Huber JC: Production and actions of estrogens. N Engl J Med. 346:340–352. 2002. View Article : Google Scholar : PubMed/NCBI

33 

Huppmann S, Römer S, Altmann R, Obladen M and Berns M: 17beta-estradiol attenuates hyperoxia-induced apoptosis in mouse C8-D1A cell line. J Neuro Res. 86:3420–3426. 2008. View Article : Google Scholar

34 

Morles DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK and Schnaper HW: Molecular and cellular cardiology: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation. 91:755–763. 1995. View Article : Google Scholar : PubMed/NCBI

35 

Shi WJ, Chen C, Zhou GM, Hu BY and Xiao HL: The role of vascular endothelial growth factor, fibroblast growth factor-2 and estrogen receptor in the pathogenesis of retinopathy of neonatal mice. Fudan Xue Bao Yi Xue Ban Bian Ji Wei Yuan Hui. 34:228–232. 2007.(In Chinese).

36 

Trotter A, Maier L, Grill HJ, Kohn T, Heckmann M and Pohlandt F: Effects of postnatal estradiol and progesterone replacement in extremely preterm infants. J Clin Endocrinol Metab. 84:4531–4535. 1999. View Article : Google Scholar : PubMed/NCBI

37 

Trotter A, Bokelmann B, Sorgo W, Bechinger-Kornhuber D, Heinemann H, Schmücker G, Oesterle M, Köhntop B, Brisch KH and Pohlandt F: Follow-up examination at the age of 15 months of extremely preterm infants after postnatal estradiol and progesterone replacement. J Clin Endocrinol Metab. 86:601–603. 2001. View Article : Google Scholar : PubMed/NCBI

38 

Trotter A, Maier L, Kohn T, Böhm W and Pohlandt F: Growth of the uterus and mammary glands and vaginal cytologic features in extremely premature infants with postnatal replacement of estradiol and progesterone. Am J Obstet Gynecol. 186:184–188. 2002. View Article : Google Scholar : PubMed/NCBI

39 

McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Müller KH, Sharkey AM and Smith SK: Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest. 98:482–489. 1996. View Article : Google Scholar : PubMed/NCBI

40 

Kaja S, Yang SH, Wei J, Fujitani K, Liu R, Brun-Zinkernagel AM, Simpkins JW, Inokuchi K and Koulen P: Estrogen protects the inner retina from apoptosis and ischemia-induced loss of Vesl-1 L/Homer 1c immunoreactive synaptic connections. Invest Ophthalmol Vis Sci. 44:3155–3162. 2003. View Article : Google Scholar : PubMed/NCBI

41 

Xu J and Su H: Body surface area calculation method for humans and animalsPharmacological Experiments. Yuanpei Zhang: Beijing Publication Group; Beijing: pp. 2411996

42 

Yuen KK and Kahn HA: The association of femal hormones with blindness from diabetic retinopathy. Am J Ophthalmol. 81:820–822. 1976. View Article : Google Scholar : PubMed/NCBI

43 

Porter JC: Hormonal regulation of breast development and activity. J Invest Dermatol. 63:85–92. 1974. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Shi W, Zhu L, Wang Y, Hu B, Xiao H, Zhou G and Chen C: Estrogen therapy to treat retinopathy in newborn mice. Exp Ther Med 10: 611-617, 2015.
APA
Shi, W., Zhu, L., Wang, Y., Hu, B., Xiao, H., Zhou, G., & Chen, C. (2015). Estrogen therapy to treat retinopathy in newborn mice. Experimental and Therapeutic Medicine, 10, 611-617. https://doi.org/10.3892/etm.2015.2554
MLA
Shi, W., Zhu, L., Wang, Y., Hu, B., Xiao, H., Zhou, G., Chen, C."Estrogen therapy to treat retinopathy in newborn mice". Experimental and Therapeutic Medicine 10.2 (2015): 611-617.
Chicago
Shi, W., Zhu, L., Wang, Y., Hu, B., Xiao, H., Zhou, G., Chen, C."Estrogen therapy to treat retinopathy in newborn mice". Experimental and Therapeutic Medicine 10, no. 2 (2015): 611-617. https://doi.org/10.3892/etm.2015.2554
Copy and paste a formatted citation
x
Spandidos Publications style
Shi W, Zhu L, Wang Y, Hu B, Xiao H, Zhou G and Chen C: Estrogen therapy to treat retinopathy in newborn mice. Exp Ther Med 10: 611-617, 2015.
APA
Shi, W., Zhu, L., Wang, Y., Hu, B., Xiao, H., Zhou, G., & Chen, C. (2015). Estrogen therapy to treat retinopathy in newborn mice. Experimental and Therapeutic Medicine, 10, 611-617. https://doi.org/10.3892/etm.2015.2554
MLA
Shi, W., Zhu, L., Wang, Y., Hu, B., Xiao, H., Zhou, G., Chen, C."Estrogen therapy to treat retinopathy in newborn mice". Experimental and Therapeutic Medicine 10.2 (2015): 611-617.
Chicago
Shi, W., Zhu, L., Wang, Y., Hu, B., Xiao, H., Zhou, G., Chen, C."Estrogen therapy to treat retinopathy in newborn mice". Experimental and Therapeutic Medicine 10, no. 2 (2015): 611-617. https://doi.org/10.3892/etm.2015.2554
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team